Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Bayer submits New Drug Application (NDA) for gadoquatrane: The investigational macrocyclic gadolinium-based contrast agent is designed for contrast-enhanced MRI of the central nervous system and other ...

Bayer announced the submission of a marketing authorization application to the Ministry of Health, Labour, and Welfare (MHLW) in Japan for its investigational contrast agent gadoquatrane for contrast ...

Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS Berlin Tuesday, June 3, 2025, 13:00 Hrs [IST] Bayer ...

On the management side, in 2023 Bayer announced the appointment of Bill Anderson to the CEO role. Anderson brings excellent credentials, including his most recent role as the CEO of Roche’s drug ...

Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being devel ...

Low dose birth control poses fewer health risks than birth control that uses high levels of estrogen. This is because high doses of estrogen are more likely to cause side effects.

Side effects are generally dose related with Rapamune. This means they’ll be more likely to happen with higher doses, but they can still happen with lower doses.

And we also found that in our study that even if we decrease the dose of Trodelvy for the first few cycles, it will not affect the efficacy of the drug. So, it gives you like same benefit in terms of ...